Blood pressure guidelines - where are we now?

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• The National Institute for Health and Clinical Excellence (NICE) updated its hypertension management guidelines in June 2006.
• The update incorporated new data on drug treatments and was developed with the British Hypertension Society (BHS).

Purpose of the Study:

• To review the updated NICE guideline for hypertension management.
• To examine the rationale behind the guideline's treatment recommendations.
• To analyze the subsequent changes in clinical practice and primary care prescribing.

Main Methods:

• Analysis of the NICE guideline update (2006) and its supporting evidence.
• Review of recently published data on primary care prescribing in England.
• Comparison with other major international hypertension guidelines.

Main Results:

• The guideline recommends calcium-channel blockers or thiazide diuretics for patients over 55, and ACE inhibitors for those under 55 as first-line therapy.
• Beta-blockers are no longer recommended for routine initial therapy.
• Evidence suggests primary care prescribing has adapted to the new NICE recommendations.

Conclusions:

• The updated NICE guideline presents specific first-line treatment strategies for hypertension based on age.
• While prescribing appears to align with the guideline, the evidence base for some recommendations remains open to debate.
• The study focuses on initial drug management in adults without comorbidities like diabetes or coronary heart disease.